United States

Point of Care (POC) Diagnostics Market size to grow by USD 14.65 billion between 2022 to 2027 | Comprehensive Analysis on Market Drivers, Trends, and Challenges by Technavio

The Point of Care (POC) Diagnostics Market is expected to grow by USD 14.65 billion between 2022 and 2027, showcasing an accelerated Compound Annual Growth Rate (CAGR) of 10.65% during this forecast period.

New York, Dec. 11, 2023 (GLOBE NEWSWIRE) — The

What are the significant segments and their growth prospects within the Point of Care Diagnostics Market?

The market segments include product categories like hematology diagnostics, infectious disease diagnostics, rapid cardiovascular diagnostics, rapid coagulation diagnostics, and others. Among these, the hematology diagnostics segment is expected to exhibit significant growth due to the high incidence of diseases such as thalassemia and anemia.

Which regions are anticipated to make substantial contributions to the growth of the Point of Care Diagnostics Market?

North America is projected to contribute around 40% to the global market growth. Factors such as the rising prevalence of chronic diseases, increased healthcare costs, and the presence of well-established vendors are driving market growth in this region. The rise in COVID-19 cases also escalated the production and demand for POC diagnostic products in North America.

Which are the major companies in the Point of Care Diagnostics Market?

Several key companies operate in the Point of Care Diagnostics Market, employing strategies like alliances, partnerships, acquisitions, geographical expansion, and product/service launches to enhance their market presence. Some of the major vendors include Abbott Laboratories, Becton Dickinson and Co., Danaher Corp., F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., Siemens AG, and more. Buy the report

Related Reports:

Point of Care (POC) HIV Testing Market: The global point of care (POC) HIV testing market size is estimated to grow by USD 290.77 million at a CAGR of 2.91% between 2022 and 2027.

Point of Care Glucose Testing Market: The point of care (POC) glucose testing market share is expected to increase to USD 972.07 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 5.44%.

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

CONTACT: Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker